electroCore, Reliefband Technologies Sign Distribution Agreement

electroCore Inc. has agreed to distribute Reliefband Technologies‘ Reletex within the U.S. Department of Veterans Affairs (VA) and other federal supply schedule (FSS) eligible entities.

Reletex is the first and only U.S. Food and Drug Administration (FDA)-cleared non-invasive neuromodulation device available by prescription for nausea and vomiting. 
 
“Reliefband is a leading innovator in wearable technology for the treatment of nausea and vomiting,” Reliefband Technologies CEO Rich Ransom said. “Partnering with electroCore to distribute our prescription non-invasive, non-drug, neuromodulation device seemed like a natural fit. We are excited about the collaboration and hopeful the relationship will provide our veterans access to another FDA cleared non-drug solution.”

Reletex is an advanced pulse generator that utilizes neuromodulation technology. It is the first Class II neuromodulation device cleared by the FDA for the therapy of nausea and vomiting. Reletex is a single patient use device and can function with its included set of non-replaceable/non-rechargeable batteries for approximately 150 hours when used on setting 3. Reletex is available by prescription for the treatment of nausea and vomiting as an adjunct to antiemetics.
 
“We are thrilled to be offering the Reletex product within VA hospitals and other FSS eligible entities,” electroCore CEO Dan Goldberger added. “We continue to build out our commercial sales organization and look for unique and complementary therapies which can be made available to our customer base. The drug-free, patient-controlled Reletex product is ideal for veterans suffering from nausea and vomiting and we believe it will be well adopted by customers who utilize neuromodulation devices such as our existing gammaCore™ therapy to treat medical conditions.”
 
Reliefband is a leader in neuromodulation and wearable technology. The company’s patented, clinically proven wearable solution quickly prevents and effectively treats nausea and vomiting. Its FDA-cleared neuromodulation technology was originally developed for use in hospitals and alters nerve activity through targeted delivery of gentle pulses to the underside of the wrist to “turn off” feelings of nausea and vomiting. Reliefband is a drug-free alternative that eliminates the discomfort associated with nausea and vomiting. 
 
electroCore Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform. Its focus is commercializing medical devices for managing and treating certain medical conditions and consumer product offerings using nVNS to promote general wellbeing and human performance in the United States and select overseas markets.